Hims & Hers Health Inc.’s stock was headed for a record session of losses Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth-consultation company less than two months after it started.
Source link
Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.
